Estela Rodriguez, Associate Director of Community Outreach in Thoracic Oncology at the University of Miami’s Sylvester Comprehensive Cancer Center, shared a post on X:
“ASCO 2026 starts tomorrow.
What are you most looking forward to learning this year?
- Role of early stage lung cancer targeted therapy.
- Strategies to overcome immunotherapy resistance.
- Potential role of GLP-1 inhibitors in cancer prevention.”
Other articles about ASCO on OncoDaily.